DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Fuchigami A, Shigiyama F, Kitazawa T. et al
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in
Japanese patients with type 2 diabetes: a prospective, randomized study
(DIVERSITY-CVR).
Cardiovascular diabetology 2020;
19: 1-11
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.